Home >Companies >News >Deals Buzz: Sanofi SA set to buy US drug maker Bioverativ for more than $11.5 billion

Mumbai: Mint brings to you your daily dose of top deals reported by newsrooms across the country.

Paytm valuation pegged at $10 billion after secondary share sale

Paytm, run by One97 Communications Ltd, is likely to be valued at about $10 billion when some existing and former employees sell a part of their shares to new investors, reports Mint, citing three people familiar with the matter. Read more

DP World, India’s NIIF to set up $3 billion investment platform

The National Investment and Infrastructure Fund (NIIF), India’s first sovereign wealth fund, and Dubai-based ports operator DP World Pvt. Ltd, on Monday, announced the creation of an investment platform to invest up to $3 billion in ports, terminals, transportation and logistics businesses in India, reports Mint. Read more

GIC, Tishman to sell WaveRock in Hyderabad for Rs2,000 crore

Singapore’s sovereign wealth fund GIC Pte. Ltd and New York-based developer Tishman Speyer are set to sell their Hyderabad-based office property WaveRock for Rs2,000 crore, reports Mint, citing two people aware of the development. Read more

AEON Learning raises $3.2 million from MEMG Family Office

Education technology startup Aeon Learning on Monday said it has raised $3.2 million from Ranjan Pai, chief executive officer (CEO) and chairman of Manipal Education and Medical Group, reports Mint. Read more

CPPIB to invest $144 million in ReNew Power Ventures

Canada Pension Plan Investment Board (CPPIB) on Monday said it is acquiring a 6.3% stake in ReNew Power Ventures Pvt. Ltd from Asian Development Bank for $144 million, reports Mint. Read more

IIFL arm to raise $500 million for maiden offshore affordable housing fund

IIFL Asset Management Ltd will begin raising its first offshore affordable housing fund of up to $500 million in the next financial year, a top company official said, even as it continues to raise a similar $500 million fund mostly from domestic investors, reports Mint. Read more

Carlyle Group leads race for 15% in Mankind Pharmaceuticals

Carlyle Group is leading the race to invest as much as $500 million for a 15% stake in Mankind Pharmaceuticals in what could become one of the largest private equity transactions in the pharma space. The transaction, if it happens, will value the Delhi-based company at about $3.3 billion, reports The Economic Times. Read more

KKR set to back Max India promoter Analjit Singh with Rs2,000-crore liquidity infusion

Seven years after giving him funds, US private equity group KKR is all set to come to the aid of Analjit Singh once again, providing him with a fresh line of ‘flexible partnership capital’ of around Rs2,000 crore ($315 million), reports The Economic Times, citing multiple people aware of discussions. Read more

Sanofi SA set to buy US drug maker Bioverativ for more than $11.5 billion: WSJ

The potential deal, which could be announced as soon as Monday, would value Bioverativ at about $105 a share, the Wall Street Journal reported. Read more

India fifth most attractive market for investments: PwC survey

India has emerged as the fifth most attractive market for investments and the optimism over global economic growth is at a record level, a survey of CEOs by global consultancy PwC said today, PTI reports. Read more

Subscribe to newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperLivemint.com is now on Telegram. Join Livemint channel in your Telegram and stay updated

My Reads Redeem a Gift Card Logout